Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 08/02/2011
PIL Salazopyrin Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/02/2011 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 17/01/2011 and displayed until 08/02/2011
Reasons for adding or updating:
  • Change to packaging
  • Change to Marketing Authorisation Holder
Updated on 20/08/2010 and displayed until 17/01/2011
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 15/10/2009 and displayed until 20/08/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 13/11/2008 and displayed until 15/10/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 21/02/2007 and displayed until 13/11/2008
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 16/08/2005 and displayed until 21/02/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 29/04/2003 and displayed until 16/08/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 20/09/2000 and displayed until 29/04/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   sulfasalazine